Atlas Trials

AZD9496 First Time in Patients Ascending Dose Study

Clinical trial NCT02248090 · COMPLETED

Trial details

NCT number
NCT02248090
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
ER+ HER2- Advanced Breast Cancer
Start date
2014-10-22
Primary completion
2017-01-31
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.